- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 21, 2025 | 9.29M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 5.52M sh |
| Capex | FY 2024 · Dec 31, 2023 | $197.15K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$25.12M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $56.57M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $10.81M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $26.64M |
| Current Assets | FY 2024 · Dec 31, 2023 | $58.91M |
| Total Assets | FY 2024 · Dec 31, 2023 | $83.94M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$7.64 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$7.64 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $23.8M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $16.52M |
| Net Income | FY 2024 · Dec 31, 2023 | −$42.19M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$38.08M |
| Revenue | FY 2024 · Dec 31, 2023 | $2.24M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $31.06M |